Financial PerformanceAdjusted EBITDA missed expectations, raising concerns about the company's financial health.
Operational ChallengesMonetizing the wavelength opportunity has fallen well behind schedule, indicating potential operational inefficiencies.
Stock ValuationThe 12-month forward business outlook does not support the stock’s current valuation, suggesting it may be overpriced.